Statins: Pharmacokinetics, Pharmacodynamics and Cost-Effectiveness Analysis

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Biochemistry

Background:

• Atherosclerosis-related cardiovascular diseases are leading causes of mortality and disability.
• Dyslipidemia, particularly elevated low-density lipoprotein cholesterol (LDL-C), is a major modifiable risk factor.
• Statins are primary therapy for lowering LDL-C and preventing cardiovascular events, with proven efficacy in halting or reversing atherosclerosis progression.

Purpose of the Study:

• To analyze the pharmacokinetic and pharmacodynamic mechanisms of statins.
• To highlight the differences among various statin molecules.
• To discuss the economic aspects and clinical implications of statin selection.

Main Methods:

• Review of pharmacokinetic and pharmacodynamic properties of statins.
• Analysis of drug absorption, bioavailability, protein binding, excretion, and solubility.
• Consideration of pleiotropic effects and economic evaluations.

Main Results:

• Statins share a common mechanism of action but exhibit distinct pharmacokinetic and pharmacodynamic profiles.
• These differences influence their clinical application and patient outcomes.
• Statins demonstrate significant cost-effectiveness in both primary and secondary cardiovascular disease prevention.

Conclusions:

• Detailed knowledge of individual statin characteristics is crucial for physicians.
• Tailoring statin choice to patient profiles optimizes therapeutic outcomes.
• Statins remain essential, cost-effective tools for managing cardiovascular disease risk.